Intuity Medical closes financing of series B amounting to $ 76 million
SUNNYVALE, California, August 1, 2011/PRNewswire /-
-funds for the permit of FDA and launching POGO ™, the first and only system of glucose control all in one
Intuity Medical, Inc., a private company that develops innovative technologies of control of glucose for the treatment of diabetes, today announced that additional funds with the closure of the second tranche of funding has been secured series preferred stock announced D above, increasing the series D up to a total of $ 76 million. A new investor, Accuitive Medical Ventures (AMV), has joined the impressive roster of investors already existing, Investor Growth Capital (IGC), Versant Ventures, U.S. Venture Partners, Thomas McNerney and Partners and Venrock, who also participated in the closure.
Intuity Medical will use the funds to get permission from the FDA and to prepare the marketing and distribution in United States of POGO all-in-One System. POGO integrates uniquely all supplies of traditional blood glucose tests within an adequate and self-sustained system, providing an easy to use higher and discretion for millions of patients who must check their glucose regularly to treat his diabetes. When combined with Patterns ™, the tool’s own data management based on the website of Intuity Medical, POGO provides a shared full platform to patients and health professionals to detect and manage important behaviors and trends that impact the overall control of glucose.
We have achieved an amount outstanding with the completion of our shipping 510 (k) and are currently awaiting permission from the FDA regarding POGO System ”, said Emory V. Anderson, managing director and Chief Executive Officer of Intuity Medical. with the additional increase in the funds, will continue to build the infrastructure of the company for the launch on the market of United States of POGO. Our goal is to make the treatment of diabetes less costly through the provision of a simple One-Step solution ™ for the current test for blood glucose ”.
Glucose control
Self-monitoring of blood glucose is estimated as US $ 8 billion global market. Clinical trials have shown that frequent glucose testing reduces the risk of complications from diabetes. The American Diabetes Association (ADA) recommends that people with diabetes who use daily insulin injections to check their glucose three or more times a day for an optimal glycaemic control.
About Intuity Medical
Intuity Medical is committed to simplifying the treatment of diabetes through the development of own and innovative technologies that help to eliminate most of the main barriers of glucose tests. POGO, Intuity Medical, the first system all-in-one designed to automate the tests in a single step, without the need for separate testing supplies. The unique integrated design of POGO provides patients a greater discretion and flexibility to test, at any time and in all places and at the frequency recommended by health professionals, and may improve glycaemic control.
If you want to learn more about POGO and Intuity Medical visit http://www.intuitymedical.com.
About Accuitive Medical Ventures
Accuitive Medical Ventures is a private company with a committed capital valued at US $ 230 million. Law firm market that aims to revolutionize the investment opportunities in medical technologies, Accuitive has specialized in the financing of risk for companies with technology and outstanding teams. The firm has established relationships with some of the main institutions to provide emerging companies and investors the opportunity to build new business unique and long-term shareholder value. Accuitive connections with some of the main drivers of the industry and prominent leaders have allowed him to add substantial value as investors and members of the Council. The firm has offices in Palo Alto, CA, Atlanta, GA and Amelia Island, FL.
If you want more information visit the website of Accuitive Medical Venture in http://www.amvpartners.com.
For more information about existing investors from Intuity Medical visit:
• Emergent Medical Partners
http://www.emvllp.com
• Investor Growth Capital
http://www.investorgrowthcapital.com
• Thomas, McNerney and Partners
http://www.tm-partners.com
• Venrock
http://www.venrock.com
• Versant Ventures
http://www.versantventures.com
• U.S. Venture Partners
http://www.usvp.com